cabergoline has been researched along with Cancer of Pancreas in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Camera, L; Carratù, A; Colao, A; de Luca di Roseto, C; Del Prete, M; Di Somma, C; Faggiano, A; Marciello, F; Marotta, V; Ramundo, V | 1 |
| Bodei, L; Colao, A; de Herder, WW; de Krijger, RR; Faggiano, A; Ferone, D; Hofland, LJ; Lamberts, SW; Lombardi, G; Pivonello, R | 1 |
2 other study(ies) available for cabergoline and Cancer of Pancreas
| Article | Year |
|---|---|
Combined biological therapy with lanreotide autogel and cabergoline in the treatment of MEN-1-related insulinomas.
Topics: Adult; Antineoplastic Agents; Cabergoline; Drug Therapy, Combination; Ergolines; Humans; Insulinoma; Male; Multiple Endocrine Neoplasia Type 1; Pancreatic Neoplasms; Peptides, Cyclic; Somatostatin; Treatment Outcome | 2014 |
Dopamine receptor expression and function in corticotroph ectopic tumors.
Topics: ACTH Syndrome, Ectopic; Adrenocorticotropic Hormone; Adult; Cabergoline; Ergolines; Female; Humans; Hydrocortisone; Lung Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Receptors, Dopamine; Reverse Transcriptase Polymerase Chain Reaction; Thymus Neoplasms | 2007 |